Zika $1.1bn Republican Funding Deal Reached; White House, Dems Condemn
Executive Summary
Under a Republican agreement to fund Zika research and development activities and other efforts to fight the virus, which passed the House early on June 23, the National Institutes of Health would get $230m, much of which would be used on the pursuit of a vaccine, while the Centers for Disease Control and Prevention would be allotted about $480m. Democrats, however, are not on board with the deal and the White House has condemned it as too little, too late.
You may also be interested in...
Zika Vaccine Timeline: Will It Be Too Little Too Late?
Following the Zika outbreak in Latin America in late 2015, a number of pharmaceutical companies have stepped up their vaccine research efforts against a virus that has now been scientifically determined as the cause of microcephaly and other severe brain defects in babies. But will a product be able to reach the market soon enough to have an impact on the current outbreak?
Fauci: 'Trust Us' Won't Fly With Pharma On Zika Funds
Declaring the Zika virus that's been spreading throughout the Americas over the past several months is "scarier" than initially thought, two top US health officials urged Congress to delay no longer and approve President Barack Obama's $1.9bn funding request to address the situation.
Robbing Ebola To Pay For Zika: Playing With Fire?
Since early this year, the Obama administration has been shifting money around to cover the costs of the work being done by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the FDA and other federal agencies to address the Zika crisis in the Americas and to prepare the US for the invasion of the virus.